161 related articles for article (PubMed ID: 28359689)
1. Frailty measure is more predictive of outcomes after curative therapy for endometrial cancer than traditional risk factors in women 60 and older.
Driver JA; Viswanathan AN
Gynecol Oncol; 2017 Jun; 145(3):526-530. PubMed ID: 28359689
[TBL] [Abstract][Full Text] [Related]
2. Functional not chronologic age: Frailty index predicts outcomes in advanced ovarian cancer.
Kumar A; Langstraat CL; DeJong SR; McGree ME; Bakkum-Gamez JN; Weaver AL; LeBrasseur NK; Cliby WA
Gynecol Oncol; 2017 Oct; 147(1):104-109. PubMed ID: 28734497
[TBL] [Abstract][Full Text] [Related]
3. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
[TBL] [Abstract][Full Text] [Related]
4. The effects of age and comorbidity on treatment and outcomes in women with endometrial cancer.
Truong PT; Kader HA; Lacy B; Lesperance M; MacNeil MV; Berthelet E; McMurtrie E; Alexander S
Am J Clin Oncol; 2005 Apr; 28(2):157-64. PubMed ID: 15803010
[TBL] [Abstract][Full Text] [Related]
5. Frailty as a predictor of all-cause mortality in older men and women.
Kulmala J; Nykänen I; Hartikainen S
Geriatr Gerontol Int; 2014 Oct; 14(4):899-905. PubMed ID: 24666801
[TBL] [Abstract][Full Text] [Related]
6. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
[TBL] [Abstract][Full Text] [Related]
7. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
Binder PS; Peipert JF; Kallogjeri D; Brooks RA; Massad LS; Mutch DG; Powell MA; Thaker PH; McCourt CK
Am J Obstet Gynecol; 2016 Dec; 215(6):766.e1-766.e9. PubMed ID: 27457116
[TBL] [Abstract][Full Text] [Related]
8. Frailty Index Developed From a Cancer-Specific Geriatric Assessment and the Association With Mortality Among Older Adults With Cancer.
Guerard EJ; Deal AM; Chang Y; Williams GR; Nyrop KA; Pergolotti M; Muss HB; Sanoff HK; Lund JL
J Natl Compr Canc Netw; 2017 Jul; 15(7):894-902. PubMed ID: 28687577
[No Abstract] [Full Text] [Related]
9. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
[TBL] [Abstract][Full Text] [Related]
10. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
11. Patterns of care and the survival of elderly patients with high-risk endometrial cancer: A case-control study from the FRANCOGYN group.
Rousselin A; Bendifallah S; Nyangoh Timoh K; Ouldamer L; Canlorbe G; Raimond E; Hudry N; Coutant C; Graesslin O; Touboul C; Collinet P; Bricou A; Huchon C; Daraï E; Ballester M; Levêque J; Lavoue V
Eur J Surg Oncol; 2017 Nov; 43(11):2135-2142. PubMed ID: 28888799
[TBL] [Abstract][Full Text] [Related]
12. Frailty: an outcome predictor for elderly gynecologic oncology patients.
Courtney-Brooks M; Tellawi AR; Scalici J; Duska LR; Jazaeri AA; Modesitt SC; Cantrell LA
Gynecol Oncol; 2012 Jul; 126(1):20-4. PubMed ID: 22522190
[TBL] [Abstract][Full Text] [Related]
13. Geriatric assessment is superior to oncologists' clinical judgement in identifying frailty.
Kirkhus L; Šaltytė Benth J; Rostoft S; Grønberg BH; Hjermstad MJ; Selbæk G; Wyller TB; Harneshaug M; Jordhøy MS
Br J Cancer; 2017 Aug; 117(4):470-477. PubMed ID: 28664916
[TBL] [Abstract][Full Text] [Related]
14. Impact of age-adjusted Charlson comorbidity score on outcomes for patients with early-stage endometrial cancer.
Robbins JR; Gayar OH; Zaki M; Mahan M; Buekers T; Elshaikh MA
Gynecol Oncol; 2013 Dec; 131(3):593-7. PubMed ID: 24125752
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of stage II endometrial cancer: The UPMC Hillman Cancer Center experience.
Chen KS; Berhane H; Gill BS; Olawaiye A; Sukumvanich P; Kelley JL; Boisen MM; Courtney-Brooks M; Comerci JT; Edwards R; Berger J; Beriwal S
Gynecol Oncol; 2017 Nov; 147(2):315-319. PubMed ID: 28866431
[TBL] [Abstract][Full Text] [Related]
16. The preoperative G8 geriatric screening tool independently predicts survival in older patients with endometrial cancer: results of a retrospective single-institution cohort study.
Anic K; Altehoefer C; Krajnak S; Schmidt MW; Schwab R; Linz VC; Schmidt M; Westphalen C; Hartmann EK; Hasenburg A; Battista MJ
J Cancer Res Clin Oncol; 2023 Feb; 149(2):851-863. PubMed ID: 35212815
[TBL] [Abstract][Full Text] [Related]
17. External validation and diagnostic value of the Elderly Functional Index version 2.0 for assessing functional status and frailty in older Danish patients with gastrointestinal cancer receiving chemotherapy: A prospective, clinical study.
Jespersen E; Soo WK; Minet LR; Eshoj HR; King MT; Pfeiffer P; Möller S
J Geriatr Oncol; 2024 Jan; 15(1):101675. PubMed ID: 38070322
[TBL] [Abstract][Full Text] [Related]
18. Redefining geriatric preoperative assessment using frailty, disability and co-morbidity.
Robinson TN; Eiseman B; Wallace JI; Church SD; McFann KK; Pfister SM; Sharp TJ; Moss M
Ann Surg; 2009 Sep; 250(3):449-55. PubMed ID: 19730176
[TBL] [Abstract][Full Text] [Related]
19. Non-hematologic predictors of mortality improve the prognostic value of the international prognostic scoring system for MDS in older adults.
Fega KR; Abel GA; Motyckova G; Sherman AE; DeAngelo DJ; Steensma DP; Galinsky I; Wadleigh M; Stone RM; Driver JA
J Geriatr Oncol; 2015 Jul; 6(4):288-98. PubMed ID: 26073533
[TBL] [Abstract][Full Text] [Related]
20. L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: pooled PORTEC trial results.
Bosse T; Nout RA; Stelloo E; Dreef E; Nijman HW; Jürgenliemk-Schulz IM; Jobsen JJ; Creutzberg CL; Smit VT
Eur J Cancer; 2014 Oct; 50(15):2602-10. PubMed ID: 25126672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
